|
|
| KDM2A_HUMAN |
KDM2A |
Lysine-specific demethylase 2A |
9.13e-62 |
0.34
|
| SC6A7_HUMAN |
SLC6A7 |
Sodium-dependent proline transporter |
1.413e-60 |
0.35
|
| KDM5C_HUMAN |
KDM5C |
Lysine-specific demethylase 5C |
8.753e-55 |
0.34
|
| KDM2B_HUMAN |
KDM2B |
Lysine-specific demethylase 2B |
1.608e-38 |
0.31
|
| HIF1N_HUMAN |
HIF1AN |
Hypoxia-inducible factor 1-alpha inhibitor |
1.609e-35 |
0.28
|
| KDM3A_HUMAN |
KDM3A |
Lysine-specific demethylase 3A |
1.654e-35 |
0.32
|
| KSYK_HUMAN |
SYK |
Tyrosine-protein kinase SYK |
1.754e-30 |
0.38
|
| KDM4C_HUMAN |
KDM4C |
Lysine-specific demethylase 4C |
1.516e-26 |
0.34
|
| KPCD1_HUMAN |
PRKD1 |
Serine/threonine-protein kinase D1 |
6.492e-26 |
0.35
|
| Q44079_AERHY |
cphA2 |
Beta-lactamase |
7.04e-23 |
0.28
|
| ANPRA_HUMAN |
NPR1 |
Atrial natriuretic peptide receptor 1 |
1.697e-21 |
0.30
|
| PGDH_HUMAN |
HPGD |
15-hydroxyprostaglandin dehydrogenase [NAD(+)] |
1.125e-20 |
0.37
|
| ECE2_HUMAN |
ECE2 |
Endothelin-converting enzyme 2 |
1.193e-19 |
0.31
|
| HCAR3_HUMAN |
HCAR3 |
Hydroxycarboxylic acid receptor 3 |
2.153e-19 |
0.44
|
| P4HA1_HUMAN |
P4HA1 |
Prolyl 4-hydroxylase subunit alpha-1 |
6.741e-19 |
0.30
|
| B9W6M3_CANDC |
CNA1 |
Serine/threonine-protein phosphatase |
2.27e-18 |
0.34
|
| ACACA_HUMAN |
ACACA |
Acetyl-CoA carboxylase 1 |
7.638e-18 |
0.33
|
| KDM4A_HUMAN |
KDM4A |
Lysine-specific demethylase 4A |
1.766e-17 |
0.33
|
| WNK1_HUMAN |
WNK1 |
Serine/threonine-protein kinase WNK1 |
1.11e-16 |
0.32
|
| LMBL3_HUMAN |
L3MBTL3 |
Lethal(3)malignant brain tumor-like protein 3 |
5.551e-16 |
0.31
|
| KPCD2_HUMAN |
PRKD2 |
Serine/threonine-protein kinase D2 |
6.084e-14 |
0.35
|
| KDM4E_HUMAN |
KDM4E |
Lysine-specific demethylase 4E |
2.042e-13 |
0.33
|
| PK3CD_MOUSE |
Pik3cd |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform |
2.495e-13 |
0.32
|
| PHF8_HUMAN |
PHF8 |
Histone lysine demethylase PHF8 |
1.543e-12 |
0.28
|
| KDM5B_HUMAN |
KDM5B |
Lysine-specific demethylase 5B |
4.726e-12 |
0.31
|
| MRGX2_HUMAN |
MRGPRX2 |
Mas-related G-protein coupled receptor member X2 |
6.464e-12 |
0.29
|
| FTO_HUMAN |
FTO |
Alpha-ketoglutarate-dependent dioxygenase FTO |
1.508e-11 |
0.28
|
| MK10_HUMAN |
MAPK10 |
Mitogen-activated protein kinase 10 |
3.192e-11 |
0.39
|
| O96526_LEIMA |
CRK3 |
Cdc2-related kinase |
2.406e-10 |
0.30
|
| KDM4D_HUMAN |
KDM4D |
Lysine-specific demethylase 4D |
5.132e-10 |
0.29
|
| M3K12_HUMAN |
MAP3K12 |
Mitogen-activated protein kinase kinase kinase 12 |
1.088e-09 |
0.42
|
| AL1A1_HUMAN |
ALDH1A1 |
Retinal dehydrogenase 1 |
4.075e-09 |
0.34
|
| TBK1_HUMAN |
TBK1 |
Serine/threonine-protein kinase TBK1 |
5.552e-09 |
0.36
|
| IKKE_HUMAN |
IKBKE |
Inhibitor of nuclear factor kappa-B kinase subunit epsilon |
5.996e-09 |
0.36
|
| CLK1_HUMAN |
CLK1 |
Dual specificity protein kinase CLK1 |
1.146e-08 |
0.37
|
| PPCE_PIG |
PREP |
Prolyl endopeptidase |
1.16e-08 |
0.31
|
| LMBL1_HUMAN |
L3MBTL1 |
Lethal(3)malignant brain tumor-like protein 1 |
1.531e-08 |
0.30
|
| KDM4B_HUMAN |
KDM4B |
Lysine-specific demethylase 4B |
2.476e-08 |
0.30
|
| SEPR_MOUSE |
Fap |
Prolyl endopeptidase FAP |
3.09e-08 |
0.29
|
| FPPS_HUMAN |
FDPS |
Farnesyl pyrophosphate synthase |
1.338e-07 |
0.32
|
| AAK1_HUMAN |
AAK1 |
AP2-associated protein kinase 1 |
3.616e-07 |
0.31
|
| LRRK2_HUMAN |
LRRK2 |
Leucine-rich repeat serine/threonine-protein kinase 2 |
8.507e-07 |
0.33
|
| ERN1_HUMAN |
ERN1 |
Serine/threonine-protein kinase/endoribonuclease IRE1 |
1.117e-06 |
0.35
|
| KDM5A_HUMAN |
KDM5A |
Lysine-specific demethylase 5A |
1.453e-06 |
0.31
|
| NEMO_HUMAN |
IKBKG |
NF-kappa-B essential modulator |
2.859e-06 |
0.31
|
| KDM6B_HUMAN |
KDM6B |
Lysine-specific demethylase 6B |
2.908e-06 |
0.28
|
| PRIO_SHEEP |
PRNP |
Major prion protein |
3.082e-06 |
0.28
|
| MBTD1_HUMAN |
MBTD1 |
MBT domain-containing protein 1 |
4.225e-06 |
0.29
|
| LIPC_HUMAN |
LIPC |
Hepatic triacylglycerol lipase |
7.595e-06 |
0.31
|
| CNR1_RAT |
Cnr1 |
Cannabinoid receptor 1 |
8.236e-06 |
0.35
|
| Q0GMK6_RABIT |
CDK4 |
Cyclin-dependent kinase 4 |
9.817e-06 |
0.29
|